DOBUTAMINE STRESS-ECHOCARDIOGRAPHY: POSSIBILITY OF CLINICAL USAGE IN CARDIOLOGY PRACTICE
https://doi.org/10.20996/1819-6446-2009-5-4-73-79
Abstract
Currently stress-echocardiography or so-called burden echocardiography is essential method of patient examination to reveal latent ischemic heart disease (IHD). That is one of the mostly informative non-invasive methods of IHD diagnosis as well as efficacy evaluation of coronary angioplasty, surgical and pharmacological treatments of IHD. Dobutamine usage as a stress-agent at burden echocardiography allows evaluating not only ischemia but a myocardial vitality in post infarction area as well as clarify severity of valve stenosis, pulmonary hypertension and extent of latent obstruction of exhaust duct of the left ventricle. Method possibilities are presented as well as test protocol, main indications and contraindications.
About the Author
M. A. Saidova
Russian Cardiology Research and Production Complex
Russian Federation
Tretya Cherepkovskaya ul. 15a, Moscow, 121552
Russian Federation
Tretya Cherepkovskaya ul. 15a, Moscow, 121552
References
1. Tennant R., Wiggers C.J. The effect of conorary occlusion on myocardial contraction. Am J Physiol. 1935;112:351-61.
2. Forrester J.S., Wyatt H.L., Da Luz P.L., et al. Functional significance of regional ischemic contraction abnormalities. Circulation 1976;54:64-70.
3. Armstrong W.F . Stress Echocardiography: Inroduction, History, and Methods. Prog. Card. Dis. 1997;39(6):499-522.
4. Olmos L.I., Dakik H., Gordon R., et al. Long-term prognostic value of exercise echocardiography compared with exercise TL-201, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998;98:2679-86.
5. Sicari R., Nihoyannopoulos P., Evangelista A. et al. Stress echocardiography expert consensus statement European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9:415–37.
6. Marcovitz P.A., Shayna V., Horn R.A. et al. The value of dobutamine stress echocardiography in determining the prognosis of patients with known or suspected coronary disease. Am J Cardiol 1996;78:404-8.
7. Marcovitz P.A.: Prognostic Issues in Stress Echocardiography. Prog Cardiovasc Dis 1997;39(6):499-522.
8. Picano E., Mathias W.J., Pignitore A., et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet 1994;344:1190-2.
9. Rahimtoola S.H. A perspective on the three large multicenter randomizid clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985 Dec;72(6 Pt 2):V123-35.
10. Braunwald E., Kloner R. The stunned myocardium: prolonged, postischemic ventricular dysfanction. Circulation 1982;66:1146-9.
11. Elefteriades J.A., Tolis GJr, Levi E. et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411- 7.
12. Di Carli M., Davidson M., Little R. et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
13. Afridi I., Kleiman N.S., Rainzer A.E., Zoghbi W.A. Dobutamine echocardiography in myocardial hibernation. Circulation 1995;91:663- 70.
14. Dilsizian V., Bonow R.O. Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 1993;87:1-20.
15. Nichimura R.A., Grantham J. A., Connolly H. M. et al. Low-output, lowgradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of the dobutamine challenge in the catheterization laboratory. Circulation 2002;106:809-13.
Review
For citations:
Saidova M.A. DOBUTAMINE STRESS-ECHOCARDIOGRAPHY: POSSIBILITY OF CLINICAL USAGE IN CARDIOLOGY PRACTICE. Rational Pharmacotherapy in Cardiology. 2009;5(4):73-79. (In Russ.) https://doi.org/10.20996/1819-6446-2009-5-4-73-79
Views:
2474
Email this article 